Final Report Of A Phase I/Ii Study Of Veliparib (Vel) In Combination With 5-Fu And Oxaliplatin (Folfox) In Patients (Pts) With Metastatic Pancreatic Cancer (Mpdac).

JOURNAL OF CLINICAL ONCOLOGY(2019)

引用 18|浏览15
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要